These processes, amplified by gut microbial shifts and SLC13A2 and SLC26A1 transporter dysregulation, create a vicious cycle where stones accelerate CKD progression while declining GFR modifies lithogenesis, shifting stone composition and exacerbating tubular stress. Here, SLC13A2 is linked to chronic kidney disease.